Ardigen, a world-leading AI Contract Research Organization (AI CRO) at the forefront of the AI transformation in the biotech and pharmaceutical sectors, is thrilled to announce the appointment of Livia Legg as the Chief Commercial Officer. Livia will also join the company’s Board of Management, bringing a wealth of leadership experience in business development and commercial operations that is poised to significantly bolster Ardigen’s sales initiatives and contribute to the company’s ambitious growth targets.
With an impressive track record of building large-scale ventures, Livia’s leadership and expertise will be instrumental in Ardigen’s strategic efforts to scale its operations by 3-5 times and expand its market presence. Her appointment underscores Ardigen’s commitment to enhancing its management team and reinforcing its mission to increase the probability of success in the drug development process.
“Livia Legg’s extensive experience in the industry and her remarkable success in business development and commercial operations make her an invaluable addition to Ardigen’s leadership team,” said Janusz Homa, CEO of Ardigen. “Her insights and strategic vision will be over the next few years crucial as we aim for ambitious growth and seek to scale our impact in the biotech and pharmaceutical sectors.”
“I am excited to join Ardigen, a purpose-driven company focused on people, culture and values,” said Livia Legg. “Ardigen is a pioneer in the AI industry leveraging our innovative platforms, scientific insights, and seamless AI integration for pharmaceutical and biotechnology companies. As we accelerate Ardigen‘s strategic growth plans, we will continue to deliver incredible value and transformative results to our clients worldwide.”
SOURCE: PRNewswire